Breaking News Instant updates and real-time market news.

GKOS

Glaukos

$30.48

-0.765 (-2.45%)

07:04
02/27/18
02/27
07:04
02/27/18
07:04

Glaukos announces iStent study results

Glaukos Corporation announced that, according to a study published in Clinical Ophthalmology, implantation of one, two or three iStent Trabecular Micro-Bypass Stents achieved mean unmedicated intraocular pressure, or IOP reductions of 30%, 37% and 43%, respectively, at 36 months postoperative. In this prospective, randomized study conducted by multiple surgeons at a single investigational site, 119 open-angle glaucoma, or OAG, subjects with preoperative unmedicated IOP of 22 mmHg to 38 mmHg received one, two or three iStents in a standalone procedure. At approximately 36 months postoperative, the one-, two- and three-stent groups achieved unmedicated mean IOP of 17.4 mmHg, 15.8 mmHg and 14.2 mmHg, respectively, compared to preoperative unmedicated mean IOP of 25.0 mmHg for the one- and two-stent groups and 25.1 mmHg for the three-stent group. At 42 months, 61%, 91% and 91% of eyes in the one-, two- and three-stent groups, respectively, achieved a =20% reduction in IOP without medication. According to the study authors, no intraoperative or perioperative complications were reported. During 42 months of postoperative follow-up, the most commonly reported adverse event was progression of pre-existing cataract. However, no eyes required additional glaucoma surgery.

  • 28

    Feb

  • 11

    Mar

GKOS Glaukos
$30.48

-0.765 (-2.45%)

12/12/17
WELS
12/12/17
NO CHANGE
Target $42
WELS
Outperform
Reimbursement remains favorable for Glaukos iStent, says Wells Fargo
After Medicare administrative contractors Palmetto and Cahaba posted their 2018 physician fee schedules for Glaukos' iStent and Alcon's CyPass, Wells Fargo analyst Larry Biegelsen notes that the 2018 rates represent a meaningful cut to iStent physician reimbursement versus 2017 rates and signal a potential continued trend of physician reimbursement cuts from the different MACs. Still even at these lower rates iStent procedures remain very profitable, the analyst argues, adding that adoption should not be meaningfully impacted by these cuts. He reiterates an Outperform rating and $42 price target on Glaukos' shares.
12/28/17
WELS
12/28/17
NO CHANGE
WELS
Outperform
Glaukos iStent inject device to reaccelerate growth, says Wells Fargo
Wells Fargo analyst Larry Biegelsen yesterday reiterated his belief that the U.S. launch of iStent inject will reaccelerate Glaukos' top line growth. The company yesterday announced that it has submitted a pre-market approval application to the FDA for the iStent inject Trabecular Micro-Bypass Stent. The analyst currently models for Glaukos worldwide sales growth of 9.2% in 2018, improving to 21.4% in 2019. Based on his channel checks, iStent inject offers clinicians with increased efficacy over the first-generation iStent product and increased ease of use. Biegelsen believes that iStent inject is the easiest of any of the microinvasive glaucoma surgery devices to implant. He keeps an Outperform rating on Glaukos.
12/28/17
CANT
12/28/17
NO CHANGE
Target $48
CANT
Overweight
Glaukos price target lowered to $48 from $60 at Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros lowered his price target for Glaukos to $48 following a model refresh heading into 2018. The anlayst, however, reiterates an Overweight rating on the shares following the company's iStent Inject device pre-market approval application filing with the FDA. While questions over competition and reimbursement dominated the last few quarters, the headwinds are manageable and investors underappreciate the long-term potential of the iStent franchise, Piros tells investors in a research note.
01/10/18
PIPR
01/10/18
NO CHANGE
Target $35
PIPR
Overweight
Glaukos price not reflecting 'unique franchise' long-term value, says Piper Jaffray
Piper Jaffray analyst Matt O'Brien notes that Glaukos released further iDose data from a cohort of 74 patients that showed sustained reduction through 12 months. The favorable profile of iDose makes it an attractive offering and a valuable pipeline product for the company, the analyst says. For the stock, O'Brien believes there is probably further MAC headline risk in the near-term and he would like to see guidance out of the way before jumping in full force. Nonetheless, the analyst thinks the current stock price does not reflect the long-term value of this "unique franchise." He reiterates an Overweight rating and $35 price target on the shares.

TODAY'S FREE FLY STORIES

COP

ConocoPhillips

$70.59

-1.425 (-1.98%)

20:13
07/16/18
07/16
20:13
07/16/18
20:13
Hot Stocks
ConocoPhillips provides 'strong' outlook for Alaska business »

ConocoPhillips provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

FSUMY

Fortescue Metal

$0.00

(0.00%)

20:08
07/16/18
07/16
20:08
07/16/18
20:08
Upgrade
Fortescue Metal rating change  »

Fortescue Metal upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEP

PepsiCo

$112.95

0.23 (0.20%)

, DISH

Dish

$32.75

-0.84 (-2.50%)

20:02
07/16/18
07/16
20:02
07/16/18
20:02
Hot Stocks
PepsiCo to replace Dish in Nasdaq-100 index effective July 23rd »

Nasdaq announced that…

PEP

PepsiCo

$112.95

0.23 (0.20%)

DISH

Dish

$32.75

-0.84 (-2.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTW

Manitowoc

$26.99

-0.52 (-1.89%)

, CAT

Caterpillar

$138.06

-2.68 (-1.90%)

20:00
07/16/18
07/16
20:00
07/16/18
20:00
Downgrade
Manitowoc, Caterpillar, Deere, Generac rating change  »

Manitowoc downgraded to…

MTW

Manitowoc

$26.99

-0.52 (-1.89%)

CAT

Caterpillar

$138.06

-2.68 (-1.90%)

DE

Deere

$136.19

-1.41 (-1.02%)

GNRC

Generac

$52.40

-0.585 (-1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 08

    Aug

CZR

Caesars

$11.63

0.075 (0.65%)

19:33
07/16/18
07/16
19:33
07/16/18
19:33
Hot Stocks
Caesars breaks ground on $375M Caesars Forum in Las Vegas »

Caesars Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

19:25
07/16/18
07/16
19:25
07/16/18
19:25
Conference/Events
Morgan Stanley telecom analyst to hold an analyst/industry conference call »

U.S. Equity Strategist…

CAAP

Corporacion America Airport

$9.87

0.08 (0.82%)

19:11
07/16/18
07/16
19:11
07/16/18
19:11
Hot Stocks
Corporacion America Airport reports June passenger traffic up 5.8% »

Corporacion America…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RIO

Rio Tinto

$53.64

-0.36 (-0.67%)

19:08
07/16/18
07/16
19:08
07/16/18
19:08
Hot Stocks
Rio Tinto announces Q2 Pilbara iron ore production 88.5Mt, up 14% from last year »

Pilbara iron ore…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

CDMO

Avid Bioservices

$4.46

-0.19 (-4.09%)

, IGT

International Game

$24.39

-0.5 (-2.01%)

19:06
07/16/18
07/16
19:06
07/16/18
19:06
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Avid…

CDMO

Avid Bioservices

$4.46

-0.19 (-4.09%)

IGT

International Game

$24.39

-0.5 (-2.01%)

BGS

B&G Foods

$29.80

-0.2 (-0.67%)

AG

First Majestic

$7.44

-0.265 (-3.44%)

NFLX

Netflix

$400.24

4.32 (1.09%)

ROKU

Roku

$48.27

-0.52 (-1.07%)

AVEO

Aveo Pharmaceuticals

$2.85

-0.055 (-1.90%)

EOLS

Evolus

$25.08

-1.12 (-4.27%)

TRQ

Turquoise Hill

$2.94

0.11 (3.89%)

CARB

Carbonite

$38.40

-0.1 (-0.26%)

RDFN

Redfin

$23.99

0.46 (1.96%)

NAKD

Naked Brand Group

$4.95

-0.15 (-2.94%)

MTW

Manitowoc

$26.99

-0.52 (-1.89%)

AMZN

Amazon.com

$1,822.02

9.02 (0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 16

    Jul

  • 16

    Jul

  • 17

    Jul

  • 18

    Jul

  • 26

    Jul

  • 02

    Aug

  • 02

    Aug

  • 16

    Aug

  • 19

    Jul

  • 19

    Jul

  • 19

    Jul

T

AT&T

$31.90

0.24 (0.76%)

18:58
07/16/18
07/16
18:58
07/16/18
18:58
Hot Stocks
Warner Bros.' 'Aquaman' film out in theaters December 21 »

Warner Bros.'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 09

    Aug

SBGI

Sinclair Broadcast

$29.10

-3.9 (-11.82%)

, TRCO

Tribune Media

$32.05

-6.55 (-16.97%)

18:57
07/16/18
07/16
18:57
07/16/18
18:57
Hot Stocks
Sinclair Broadcast 'shocked and disappointed' by FCC Chairman Pai's statement »

Sinclair Broadcast Group…

SBGI

Sinclair Broadcast

$29.10

-3.9 (-11.82%)

TRCO

Tribune Media

$32.05

-6.55 (-16.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 06

    Sep

DE

Deere

$136.19

-1.41 (-1.02%)

18:49
07/16/18
07/16
18:49
07/16/18
18:49
Downgrade
Deere rating change  »

Deere downgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAT

Caterpillar

$138.06

-2.68 (-1.90%)

18:49
07/16/18
07/16
18:49
07/16/18
18:49
Downgrade
Caterpillar rating change  »

Caterpillar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 08

    Aug

RIO

Rio Tinto

$53.64

-0.36 (-0.67%)

18:48
07/16/18
07/16
18:48
07/16/18
18:48
Hot Stocks
Rio Tinto says FY18 Pilbara shipments will be at upper end of prior forecast »

Rio Tinto states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

NFLX

Netflix

$400.24

4.32 (1.09%)

18:41
07/16/18
07/16
18:41
07/16/18
18:41
Hot Stocks
Breaking Hot Stocks news story on Netflix »

Netflix CEO: Still not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

NFLX

Netflix

$400.24

4.32 (1.09%)

18:39
07/16/18
07/16
18:39
07/16/18
18:39
Hot Stocks
Breaking Hot Stocks news story on Netflix »

Netflix says debt remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

IBM

IBM

$145.43

-0.48 (-0.33%)

, GRPN

Groupon

$4.70

0.025 (0.53%)

18:32
07/16/18
07/16
18:32
07/16/18
18:32
Periodicals
IBM seeks $166.5M in damages from Groupon in patent lawsuit, Bloomberg says »

IBM (IBM) is requesting…

IBM

IBM

$145.43

-0.48 (-0.33%)

GRPN

Groupon

$4.70

0.025 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

LGF.A

Lionsgate

$25.33

-0.58 (-2.24%)

, LGF.B

Lionsgate

$23.85

-0.69 (-2.81%)

18:30
07/16/18
07/16
18:30
07/16/18
18:30
Hot Stocks
Lionsgate announces Dr. John Malone, Scott Paterson to retire from board »

On July 11, Dr. John…

LGF.A

Lionsgate

$25.33

-0.58 (-2.24%)

LGF.B

Lionsgate

$23.85

-0.69 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

GNRC

Generac

$52.40

-0.585 (-1.10%)

18:30
07/16/18
07/16
18:30
07/16/18
18:30
Downgrade
Generac rating change  »

Generac downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTW

Manitowoc

$26.99

-0.52 (-1.89%)

18:29
07/16/18
07/16
18:29
07/16/18
18:29
Downgrade
Manitowoc rating change  »

Manitowoc downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$400.24

4.32 (1.09%)

18:27
07/16/18
07/16
18:27
07/16/18
18:27
Hot Stocks
Breaking Hot Stocks news story on Netflix »

Netflix CEO says median…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

NFLX

Netflix

$400.24

4.32 (1.09%)

18:25
07/16/18
07/16
18:25
07/16/18
18:25
Hot Stocks
Netflix says far from reaching a limit on pricing in India »

Constantly testing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

FCPT

Four Corners Property Trust

$24.83

-0.06 (-0.24%)

18:24
07/16/18
07/16
18:24
07/16/18
18:24
Hot Stocks
Four Corners Property Trust acquires Buffalo Wild Wings restaurant for $3.6M »

Four Corners Property…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASOMY

Asos

$0.00

(0.00%)

18:14
07/16/18
07/16
18:14
07/16/18
18:14
Upgrade
Asos rating change at Goldman Sachs »

Asos upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$400.24

4.32 (1.09%)

18:11
07/16/18
07/16
18:11
07/16/18
18:11
Hot Stocks
Breaking Hot Stocks news story on Netflix »

Netflix says adoption of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.